Literature DB >> 20224861

Medullary thyroid cancer: are practice patterns in the United States discordant from American Thyroid Association guidelines?

Babita Panigrahi1, Sanziana A Roman, Julie Ann Sosa.   

Abstract

BACKGROUND: Surgery is the mainstay of treatment for medullary thyroid cancer (MTC), with long-term patient outcomes associated with adequacy of resection. This study benchmarked national practice patterns against 2009 American Thyroid Association (ATA) guidelines for MTC regarding use of thyroidectomy, lymphadenectomy, radioactive iodine (RAI), and external-beam radiotherapy (EBRT).
METHODS: This is a cross-sectional, retrospective cohort study of MTC patients in the Surveillance, Epidemiology, and End Results Program database, 1973 to 2006. ATA recommendations 61 to 66 (extent of surgery), 85 (RAI), and 93 (EBRT) were analyzed. Outcome of interest was practice accordance with these recommendations. Predictors of accordance were determined and Kaplan-Meier survival analyses were performed.
RESULTS: A total of 2033 patients with MTC were identified. Fifty-nine percent were women; 78% were white. Forty-one percent of patients did not receive appropriate surgical therapy (recommendations 61 to 63). Most patients with distant metastatic disease had less aggressive surgery and more EBRT (P < 0.001) (recommendations 64 to 66). Four percent of patients received inappropriate RAI (recommendation 85). Two hundred nine patients had gross incomplete resections, with 33% receiving postoperative EBRT (recommendation 93). Statistically significant predictors of receiving surgery discordant with ATA recommendations in multivariate analysis were patient age >65, female sex, earlier year of diagnosis (1988 to 1997), geographic region, intrathyroidal tumor extent, and tumor size of </=1 cm. Patients receiving surgery discordant with recommendations had shorter survival than those receiving surgery according to recommendations (P < 0.05).
CONCLUSIONS: Variation in practice patterns exist in the United States with regard to extent of surgery and lymphadenectomy for MTC. Dissemination of standardized guidelines is important to ensure optimal treatment with less variation in quality of care.

Entities:  

Mesh:

Year:  2010        PMID: 20224861     DOI: 10.1245/s10434-010-1017-0

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  19 in total

Review 1.  Surgical management of medullary thyroid carcinoma.

Authors:  Agathoklis Konstantinidis; Michael Stang; Sanziana A Roman; Julie Ann Sosa
Journal:  Updates Surg       Date:  2017-04-13

2.  Adherence to and uptake of clinical practice guidelines: lessons learned from a clinical practice guideline on chemotherapy concomitant with radiotherapy in head-and-neck cancer.

Authors:  S F Hall; J C Irish; R W Gregg; P A Groome; S Rohland
Journal:  Curr Oncol       Date:  2015-04       Impact factor: 3.677

3.  Trends in the presentation, treatment, and survival of patients with medullary thyroid cancer over the past 30 years.

Authors:  Reese W Randle; Courtney J Balentine; Glen E Leverson; Jeffrey A Havlena; Rebecca S Sippel; David F Schneider; Susan C Pitt
Journal:  Surgery       Date:  2016-11-11       Impact factor: 3.982

4.  Preoperative basal calcitonin and tumor stage correlate with postoperative calcitonin normalization in patients undergoing initial surgical management of medullary thyroid carcinoma.

Authors:  Dana T Yip; Maria Hassan; Kalliopi Pazaitou-Panayiotou; Daniel T Ruan; Atul A Gawande; Randall D Gaz; Francis D Moore; Richard A Hodin; Antonia E Stephen; Peter M Sadow; Gilbert H Daniels; Gregory W Randolph; Sareh Parangi; Carrie C Lubitz
Journal:  Surgery       Date:  2011-12       Impact factor: 3.982

Review 5.  Multikinase Inhibitors for the Treatment of Progressive, Metastatic Medullary Thyroid Cancer - An Evolving Paradigm.

Authors:  Barbara Jarzab; Jolanta Krajewska
Journal:  Eur Endocrinol       Date:  2014-08-28

Review 6.  Medullary thyroid cancer--current treatment strategy, novel therapies and perspectives for the future.

Authors:  Masahiro Sugawara; Tran Ly; Jerome M Hershman
Journal:  Horm Cancer       Date:  2012-08-04       Impact factor: 3.869

7.  National Trends in the Surgical Treatment of Non-advanced Medullary Thyroid Cancer (MTC): An Evaluation of Adherence with the 2009 American Thyroid Association Guidelines.

Authors:  Eun Hae Estelle Chang; Waseem Lutfi; Joseph Feinglass; Alexandra Eudokia Reiher; Tricia Moo-Young; Mihir Kiran Bhayani
Journal:  World J Surg       Date:  2016-12       Impact factor: 3.352

8.  Risk Factors Associated With Reoperation and Disease-Specific Mortality in Patients With Medullary Thyroid Carcinoma.

Authors:  Eric J Kuo; Shonan Sho; Ning Li; Kyle A Zanocco; Michael W Yeh; Masha J Livhits
Journal:  JAMA Surg       Date:  2018-01-01       Impact factor: 14.766

9.  Multifocality in Sporadic Medullary Thyroid Carcinoma: An International Multicenter Study.

Authors:  Garth F Essig; Kyle Porter; David Schneider; Debora Arpaia; Susan C Lindsey; Giulia Busonero; Daniel Fineberg; Barbara Fruci; Kristien Boelaert; Johannes W Smit; Johannes Arnoldus Anthonius Meijer; Leonidas H Duntas; Neil Sharma; Giuseppe Costante; Sebastiano Filetti; Rebecca S Sippel; Bernadette Biondi; Duncan J Topliss; Furio Pacini; Rui M B Maciel; Patrick C Walz; Richard T Kloos
Journal:  Thyroid       Date:  2016-10-11       Impact factor: 6.568

10.  Clinical and economic outcomes of thyroid surgery in elderly patients: a systematic review.

Authors:  Michael C Sullivan; Sanziana A Roman; Julie A Sosa
Journal:  J Thyroid Res       Date:  2012-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.